Publications by authors named "Hazem Rezq"
Background: Cardiogenic shock is a critical cardiac condition characterized by low cardiac output leading to end-organ hypoperfusion and associated with high in-hospital mortality rates. It can manifest following acute myocardial infarction or acute exacerbation of chronic heart failure. Despite advancements, mortality rates remain elevated, prompting interest in multidisciplinary approaches to improve outcomes.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates the impact of single arterial cannulation (SAC) versus double arterial cannulation (DAC) during repairs for acute type A aortic dissection, focusing on patient outcomes such as hospital stay and complications.
- A systematic review of 7 studies involving 3,534 patients revealed that DAC led to longer stays in intensive care but did not significantly affect overall length of hospital stay or rates of stroke, paraplegia, or acute kidney injury compared to SAC.
- The findings suggest that while DAC could be associated with higher risks of complications like need for dialysis or reintubation, overall clinical outcomes remain comparable, underscoring the importance of individualized cannulation strategies for patients.*
Background: Cabozantinib, a new first-line treatment for advanced renal cell carcinoma (aRCC), targets essential tyrosine kinases and outperforms the established comparator (sunitinib) in various efficacy outcomes. This systematic review and meta-analysis aimed to assess the efficacy and safety of cabozantinib compared to other aRCC treatments.
Methods: Following PRISMA and Cochrane guidelines, our protocol was registered in PROSPERO.
Background And Objective: Plasma is a critical element in hemostatic resuscitation post-injury, and its prompt administration within the prehospital setting may reduce the complications resulting from hemorrhage and shock. Our objective is to assess the efficacy and safety of prehospital plasma infusion in patients susceptible to hemorrhagic shock.
Methods: We conducted our study by aggregating randomized controlled trials (RCTs) sourced from PubMed, EMBASE, Scopus, Web of Science, and Cochrane CENTRAL up to January 29, 2023.